Meridian Bioscience Inc (NASDAQ:VIVO)

26.00
BATS BZX Real-Time Price
As of 12:21pm ET
 +0.02 / +0.08%
Today’s Change
17.00
Today|||52-Week Range
28.72
+27.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Contact Information

Meridian Bioscience, Inc.
3471 River Hills Drive
Cincinnati Ohio 45244
P:(513) 271-3700
Investor Relations:
1513

Employees

Shareholders

Mutual fund holders55.18%
Individual stakeholders5.75%
Other institutional44.74%

Top Executives

John Patrick KennyChief Executive Officer & Executive Director
Andrew S. KitzmillerChief Financial Officer & Executive Vice President
Julie SmithChief Accounting Officer, Senior VP & Controller
Lourdes WeltzienExecutive Vice President-Life Science
Tony Serafini-LamannaExecutive Vice President-Diagnostics